University of California San Francisco

John Roberts, MD
John
Roberts
MD

Professor of Surgery
Division of Transplant Surgery
Endowed Chair in Abdominal Transplantation

Address

400 Parnassus Avenue, #A730K
San Francisco, CA 94117
United States

Email: [email protected]
Phone: 415-353-9321
Fax: 415-353-8709

Biography

Dr. John Roberts is a surgeon with expertise that includes kidney, liver and pancreas transplants. He is also an expert in surgically managing liver diseases, such as portal hypertension (high blood pressure in the vein going from the digestive organs to the liver), as well as in liver surgery for cancer.

Roberts is one of the few surgeons in the U.S. who has extensive experience in performing the Rex shunt – a procedure that restores normal blood flow to the liver – in children and adults. He also has spearheaded an effort to expand the use of living donors for liver transplantation, one of his many projects to make more organs available.

Roberts earned his medical degree at the University of California, San Diego and completed a surgical residency at the University of Washington. He also served as a postdoctoral fellow in transplantation in the Department of Surgery at the University of Minnesota Medical School.

Roberts joined UCSF Medical Center in 1988. In addition to his leadership of the transplant service, he teaches medical students and supervises the training of surgical residents.

Roberts has won numerous awards and has received grants from the National Institutes of Health for his research. He has produced nearly 170 papers on topics that include organ transplant rejection, immunogenicity (ability of a substance to provoke an immune response) and immunosuppression (intentionally subduing immune response to lower the chance of organ rejection).

Roberts speaks nationally on transplant issues. He is a fellow of the American Surgical Association and a member of many professional organizations.

Videos

Education

Institution Degree Dept or School End Date
University of California, San Francisco Residency

Board Certifications

  • American Board of Surgery, 1988, renewed 2006

Clinical Expertise

Acute Liver Failure

Bile Duct Injuries

Bile Duct Strictures

Bile Duct Cancer (Cholangiocarcinoma)

Liver Cancer (Hepatocellular Carcinoma)

Choledochal Cyst Disease

Complex Cancer Resections

Expanded Criteria Donor Kidney Transplant

Fulminant Hepatic Failure

Infections Post-Transplant

Kidney Transplant

Liver Resection

Liver Transplant

Living Donor Liver Transplant

Living Donor Kidney Transplant

Pediatric Liver Transplant

Pediatric Kidney Transplant

Portal Hypertension

Rex Shunt or Meso-portal Shunt

Surgical Shunts

In the News

New AASLD Video Showcases UCSF Liver Transplant Program
December, 20, 2014 | UCSF Transplant Surgery

Grants and Funding

  • TRANSPLANTATION AND HEPATOTOXINS FOR LIVER CANCER | NIH | 1993-01-01 - 1997-12-31 | Role: Principal Investigator

Research Interests

  • Ethical Issues in Transplantation
  • Organ Allocation
  • Cost of Transplantation
  • Immunosuppression

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 252
  1. The Cost of Procuring Deceased Donor Livers: Evidence From US Organ Procurement Organization Cost Reports, 2013-2018.
    Bragg-Gresham JL, Peters TG, Vaughan WP, Held P, McCormick F, Roberts JP| | PubMed
  2. The Medical Costs of Determining Eligibility and Waiting for a Kidney Transplantation.
    Xu K, Dor A, Mohanty S, Han J, Parvathinathan G, Braggs-Gresham JL, Held PJ, Roberts JP, Vaughan W, Tan JC, Scandling JD, Chertow GM, Busque S, Cheng XS| | PubMed
  3. Successful living donor liver transplant from donor with false-positive human immunodeficiency virus test in recipient without human immunodeficiency virus.
    Fung M, La Hoz RM, Durand CM, Lee DH, Sears D, Hohe C, Chin-Hong P, Roberts JP| | PubMed
  4. Rate of Deceased Kidney Donation From Potential In-Hospital Deaths in the US, 2003-2021.
    Bragg-Gresham J, Licon AL, Kiryakos J, Saran R, Roberts JP| | PubMed
  5. Report From a Multidisciplinary Symposium on the Future of Living Kidney Donor Transplantation.
    Peters TG, Fung JJ, Radcliffe-Richards J, Satel S, Roth AE, McCormick F, Gershun M, Matas AJ, Roberts JP, Morrison J, Chertow GM, Lee LD, Held PJ, Ojo A| | PubMed
  6. Pretransplantation coronavirus disease 2019 vaccination requirements: A matched case-control study of factors associated with waitlist inactivation.
    Edwards AL, Tavakol MM, Mello A, Kerney J, Roberts JP| | PubMed
  7. Characterizing the risk of human leukocyte antigen-incompatible living donor kidney transplantation in older recipients.
    Long JJ, Motter JD, Jackson KR, Chen J, Orandi BJ, Montgomery RA, Stegall MD, Jordan SC, Benedetti E, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Verbesey JE, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Wellen JR, Bozorgzadeh A, Gaber AO, Heher EC, Weng FL, Djamali A, Helderman JH, Concepcion BP, Brayman KL, Oberholzer J, Kozlowski T, Covarrubias K, Massie AB, McAdams-DeMarco MA, Segev DL, Garonzik-Wang JM| | PubMed
  8. DCD liver transplant in patients with a MELD over 35.
    Meier RPH, Nunez M, Syed SM, Feng S, Tavakol M, Freise CE, Roberts JP, Ascher NL, Hirose R, Roll GR| | PubMed
  9. Living Donor Liver Transplantation for Hepatocellular Carcinoma Within and Outside Traditional Selection Criteria: A Multicentric North American Experience.
    Ivanics T, Claasen MPAW, Samstein B, Emond JC, Fox AN, Pomfret E, Pomposelli J, Tabrizian P, Florman SS, Mehta N, Roberts JP, Emamaullee JA, Genyk Y, Hernandez-Alejandro R, Tomiyama K, Sasaki K, Hashimoto K, Nagai S, Abouljoud M, Olthoff KM, Hoteit MA, Heimbach J, Taner T, Liapakis AH, Mulligan DC, Sapisochin G, Halazun KJ, North American Living Liver Donor Innovation Group (NALLDIG)| | PubMed
  10. Real-world implementation of normothermic machine perfusion: A detailed analysis of intraoperative and early postoperative impact.
    Dixon W, Sheetz K, Adelmann D, Bokoch M, Reddy M, Kothari R, Roberts JP, Syed S, Feng S, Roll G| | PubMed
  11. Comments on Experience With Establishing a Robotic Donor Hepatectomy Program for Pediatric Liver Transplantation.
    Ascher NL, Roberts JP| | PubMed
  12. Steroid Avoidance After Adult Living Donor Liver Transplant: A Cohort Analysis.
    Nunez M, Praglin CR, Torres AM, Agudelo EZ, Braun HJ, Huang CY, Syed S, Roberts JP, Roll GR| | PubMed
  13. Corrigendum to 'Assessment of long-term outcomes post living liver donation highlights the importance of scientific integrity when presenting transplant registry data' [American Journal of Transplantation. Volume 22, Issue 6, March 2023, Pages 1519-1522].
    Emamaullee J, Heimbach JK, Olthoff KM, Pomfret EA, Roberts JP, Selzner N, NALLDIG Consortium| | PubMed
  14. Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conference.
    Jesse MT, Jackson WE, Liapakis A, Ganesh S, Humar A, Goldaracena N, Levitsky J, Mulligan D, Pomfret EA, Ladner DP, Roberts JP, Mavis A, Thiessen C, Trotter J, Winder GS, Griesemer AD, Pillai A, Kumar V, Verna EC, LaPointe Rudow D, Han HH, AST LDLT Consensus Conference Working Group| | PubMed
  15. Influence of surgical technique in donor hepatectomy on immediate and short-term living donor outcomes - A systematic review of the literature, meta-analysis, and expert panel recommendations.
    Cheah YL, Heimbach J, Kwon CHD, Pomposelli J, Rudow DL, Broering D, Spiro M, Raptis DA, Roberts JP, ERAS4OLT.org Working Group| | PubMed
  16. Editorial: Optimizing Outcomes for Children Requires Ensuring Access to Living: Donor and Split Liver Transplants.
    Perito ER, Roberts JP| | PubMed
  17. Projecting the Economic Impact of Compensating Living Kidney Donors in the United States: Cost-Benefit Analysis Demonstrates Substantial Patient and Societal Gains.
    McCormick F, Held PJ, Chertow GM, Peters TG, Roberts JP| | PubMed
  18. Nodular Regenerative Hyperplasia After Liver Transplant; It's All in the Presentation.
    Chen AK, Lunow-Luke T, Yamaguchi S, Praglin C, Agudelo E, Mehta N, Dirks R, Braun HJ, Gardner JM, Roberts JP, Syed SM, Roll GR| | PubMed
  19. Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy.
    Simões EAF, Center KJ, Tita ATN, Swanson KA, Radley D, Houghton J, McGrory SB, Gomme E, Anderson M, Roberts JP, Scott DA, Jansen KU, Gruber WC, Dormitzer PR, Gurtman AC| | PubMed
  20. Assessment of long-term outcomes post living liver donation highlights the importance of scientific integrity when presenting transplant registry data.
    Emamaullee J, Heimbach JK, Olthoff KM, Pomfret EA, Roberts JP, Selzner N, NALLDIG Consortium*| | PubMed
  21. Consent to organ offers from public health service "Increased Risk" donors decreases time to transplant and waitlist mortality.
    Kelly YM, Zarinsefat A, Tavakol M, Shui AM, Huang CY, Roberts JP| | PubMed
  22. Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017.
    Cheng XS, Han J, Braggs-Gresham JL, Held PJ, Busque S, Roberts JP, Tan JC, Scandling JD, Chertow GM, Dor A| | PubMed
  23. The use of nondirected donor organs in living donor liver transplantation: Perspectives and guidance.
    Fox AN, Liapakis A, Batra R, Bittermann T, Emamaullee J, Emre S, Genyk Y, Han H, Jackson W, Pomfret E, Raza M, Rodriguez-Davalos M, Rubman Gold S, Samstein B, Shenoy A, Taner T, Roberts JP, North American Living Liver Donor Innovations Group (NALLDIG)| | PubMed
  24. Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation.
    Meier RPH, Kelly Y, Yamaguchi S, Braun HJ, Lunow-Luke T, Adelmann D, Niemann C, Maluf DG, Dietch ZC, Stock PG, Kang SM, Feng S, Posselt AM, Gardner JM, Syed SM, Hirose R, Freise CE, Ascher NL, Roberts JP, Roll GR| | PubMed
  25. Cost Structures of US Organ Procurement Organizations.
    Held PJ, Bragg-Gresham JL, Peters TG, McCormick F, Chertow G, Vaughan WP, Roberts JP| | PubMed
  26. Liver transplant in children and adults with cystic fibrosis: Impact of growth failure and nutritional status.
    Cheng K, Rosenthal P, Roberts JP, Perito ER| | PubMed
  27. With the Proven Tenacity of Waitlist Mortality, Shouldn't We Resist the Urge to Make Mountains Out of Survival Statistic Molehills?
    Roll GR, Roberts JP| | PubMed
  28. Retransplantation After Living Donor Liver Transplantation: Data from the Adult to Adult Living Donor Liver Transplantation Study.
    Braun HJ, Grab JD, Dodge JL, Syed SM, Roll GR, Schwab MP, Liu IH, Glencer AC, Freise CE, Roberts JP, Ascher NL| | PubMed
  29. Estimated impact of novel coronavirus-19 and transplant center inactivity on end-stage renal disease-related patient mortality in the United States.
    Peters TG, Bragg-Gresham JL, Klopstock AC, Roberts JP, Chertow G, McCormick F, Held PJ| | PubMed
  30. The organ procurement costs of expanding deceased donor organ acceptance criteria: Evidence from a cost function model.
    Cheng XS, Held PJ, Dor A, Bragg-Gresham JL, Tan JC, Scandling JD, Chertow GM, Roberts JP| | PubMed
  31. Non-operative management of biliary complications after Liver Transplantation in pediatric patients: A 30-year experience.
    Lee AY, Lehrman ED, Perito ER, Kerlan RK, Kohi MP, Kolli KP, Taylor AG, Ostroff JW, Kang SM, Roberts JP, Rhee S, Rosenthal P, Fidelman N| | PubMed
  32. Current status of left lobe adult to adult living donor liver transplantation.
    Braun HJ, Roberts JP| | PubMed
  33. Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization.
    Braun HJ, Dodge JL, Grab JD, Schwab ME, Liu IH, Glencer AC, Stock PG, Hirose R, Roberts JP, Ascher NL| | PubMed
  34. Emergency general surgery utilization and disparities during COVID-19: an interrupted time-series analysis.
    Greenberg AL, Schwartz H, Collins CR, Kelly YM, Mackersie R, Mourad M, Roberts JP, Bongiovanni T| | PubMed
  35. Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation.
    Motter JD, Jackson KR, Long JJ, Waldram MM, Orandi BJ, Montgomery RA, Stegall MD, Jordan SC, Benedetti E, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Verbesey JE, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Wellen JR, Bozorgzadeh A, Gaber AO, Heher EC, Weng FL, Djamali A, Helderman JH, Concepcion BP, Brayman KL, Oberholzer J, Kozlowski T, Covarrubias K, Massie AB, Segev DL, Garonzik-Wang JM| | PubMed
  36. A world-wide survey on kidney transplantation practices in breast cancer survivors: The need for new management guidelines.
    Hansen KS, Ghersin H, Piper M, Tavakol M, Lee B, Esserman LJ, Roberts JP, Freise C, Ascher NL, Mukhtar RA| | PubMed
  37. Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes.
    Jackson KR, Long J, Motter J, Bowring MG, Chen J, Waldram MM, Orandi BJ, Montgomery RA, Stegall MD, Jordan SC, Benedetti E, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Verbesey JE, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Wellen J, Bozorgzadeh A, Gaber AO, Heher E, Weng FL, Djamali A, Helderman JH, Concepcion BP, Brayman KL, Oberholzer J, Kozlowski T, Covarrubias K, Desai N, Massie AB, Segev DL, Garonzik-Wang J| | PubMed
  38. Setting rules for the sandbox: A response to "Successfully sharing the sandbox: A perspective on combined DCD liver and heart donor procurement".
    Wisel SA, Thiessen C, Day R, Belin LJ, Syed SM, Hirose R, Ascher N, Roberts JP, Freise CE| | PubMed
  39. Expanding living donor liver transplantation: Report of first US living donor liver transplant chain.
    Braun HJ, Torres AM, Louie F, Weinberg SD, Kang SM, Ascher NL, Roberts JP| | PubMed
  40. Reducing the Shortage of Transplant Kidneys: A Lost Opportunity for the US Health Resources and Services Administration (HRSA).
    McCormick F, Held PJ, Chertow GM, Peters TG, Roberts JP| | PubMed
  41. Opioid use prior to liver transplant is associated with increased risk of death after transplant.
    Braun HJ, Schwab MP, Jin C, Amara D, Mehta NJ, Grace TR, Croci R, Freise CE, Roberts JP, Hirose R, Ascher NL| | PubMed
  42. A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
    Mehta N, Dodge JL, Roberts JP, Yao FY| | PubMed
  43. Contemporary Management of Hepatic Cyst Disease: Techniques and Outcomes at a Tertiary Hepatobiliary Center.
    Gomez A, Wisneski AD, Luu HY, Hirose K, Roberts JP, Hirose R, Freise CE, Nakakura EK, Corvera CU| | PubMed
  44. Consensus-based perioperative protocols during the COVID-19 pandemic.
    Mummaneni PV, Burke JF, Chan AK, Sosa JA, Lobo EP, Mummaneni VP, Antrum S, Berven SH, Conte MS, Doernberg SB, Goldberg AN, Hess CP, Hetts SW, Josephson SA, Kohi MP, Ma CB, Mahadevan VS, Molinaro AM, Murr AH, Narayana S, Roberts JP, Stoller ML, Theodosopoulos PV, Vail TP, Wienholz S, Gropper MA, Green A, Berger MS| | PubMed
  45. Post-operative assessment in patients after liver transplantation: imaging parameters associated with 1-year graft failure.
    Chang WC, M Yeh B, Chu L, Kim SY, Wen KW, Chiu SH, Ding CC, Wu EH, Roberts JP, Huang GS, Hsu HH| | PubMed
  46. A Virtual Crossmatch-based Strategy Facilitates Sharing of Deceased Donor Kidneys for Highly Sensitized Recipients.
    Roll GR, Webber AB, Gae DH, Laszik Z, Tavakol M, Mayen L, Cunniffe K, Syed S, Hirose R, Freise C, Feng S, Roberts JP, Ascher NL, Stock PG, Rajalingam R| | PubMed
  47. Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Mehta N, Bhangui P, Yao FY, Mazzaferro V, Toso C, Akamatsu N, Durand F, Ijzermans J, Polak W, Zheng S, Roberts JP, Sapisochin G, Hibi T, Kwan NM, Ghobrial M, Soin A| | PubMed
  48. Living Donor Liver Transplant for Alcoholic Liver Disease: Data from the Adult-to-adult Living Donor Liver Transplantation Study.
    Braun HJ, Dodge JL, Grab JD, Syed SM, Roll GR, Freise CE, Roberts JP, Ascher NL| | PubMed
  49. Overdilation of a 6-mm Self-Expanding Stent with a 10-mm Balloon-Expandable Stent Graft Preserves Failing Meso-Rex Bypass.
    Koethe Y, Lokken RP, Lehrman ED, Kerlan RK, Roberts JP, Rhee SJ, Kohi MP, Kolli KP| | PubMed
  50. The Authors' Reply: Biliary Bicarbonate, pH, and Glucose Are Suitable Biomarkers of Biliary Viability During Ex Situ Normothermic Machine Perfusion of Human Donor Livers.
    Meier RPH, Syed S, Roberts JP| | PubMed
  51. Split liver transplantation is utilized infrequently and concentrated at few transplant centers in the United States.
    Ge J, Perito ER, Bucuvalas J, Gilroy R, Hsu EK, Roberts JP, Lai JC| | PubMed
  52. The cost of procuring deceased donor kidneys: Evidence from OPO cost reports 2013-2017.
    Held PJ, Bragg-Gresham JL, Peters T, Chertow GM, McCormick F, Roberts JP| | PubMed
  53. Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates.
    Swenson SM, Roberts JP, Rhee S, Perito ER| | PubMed
  54. Removing Disincentives to Kidney Donation: A Quantitative Analysis.
    McCormick F, Held PJ, Chertow GM, Peters TG, Roberts JP| | PubMed
  55. Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve.
    Fidelman N, Johanson C, Kohi MP, Kolli KP, Kohlbrenner RM, Lehrman ED, Taylor AG, Kelley RK, Yao FY, Roberts JP, Kerlan RK| | PubMed
  56. Noninvasive estimation of pulmonary vascular resistance improves portopulmonary hypertension screening in liver transplant candidates.
    DesJardin JT, Manicardi M, Svetlichnaya Y, Kolaitis NA, Papolos AI, Selby VN, Zier LS, Klein L, Aras MA, Yao FY, Roberts JP, De Marco T| | PubMed
  57. Bi-organ paired exchange-Sentinel case of a liver-kidney swap.
    Torres AM, Wong F, Pearson S, Weinberg S, Roberts JP, Ascher NL, Freise CE, Lee BK| | PubMed
  58. Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation.
    Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY| | PubMed
  59. Split Liver Transplantation and Pediatric Waitlist Mortality in the United States: Potential for Improvement.
    Perito ER, Roll G, Dodge JL, Rhee S, Roberts JP| | PubMed
  60. Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
    Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY| | PubMed
  61. Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A-VENA Criteria.
    Sherman CB, Behr S, Dodge JL, Roberts JP, Yao FY, Mehta N| | PubMed
  62. Preoperative Autologous Blood Collection in Adult Living Liver Donors: Are We Wasting Donor Blood and Increasing Exposure to Risk?
    Manuel SP, Roberts JP, Bakhtary S| | PubMed
  63. The mRECIST Classification Provides Insight into Tumor Biology for Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation.
    Lee DD, Samoylova M, Mehta N, Musto KR, Roberts JP, Yao FY, Harnois DM| | PubMed
  64. Should Patients With NAFLD/NASH Be Surveyed for HCC?
    Reig M, Gambato M, Man NK, Roberts JP, Victor D, Orci LA, Toso C| | PubMed
  65. Would government compensation of living kidney donors exploit the poor? An empirical analysis.
    Held PJ, McCormick F, Chertow GM, Peters TG, Roberts JP| | PubMed
  66. Increasing Liver Transplantation Wait-List Dropout for Hepatocellular Carcinoma With Widening Geographical Disparities: Implications for Organ Allocation.
    Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY| | PubMed
  67. Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma.
    Samoylova ML, Mehta N, Roberts JP, Yao FY| | PubMed
  68. Alpha-Fetoprotein Slope >7.5 ng/mL per Month Predicts Microvascular Invasion and Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma.
    Giard JM, Mehta N, Dodge JL, Roberts JP, Yao FY| | PubMed
  69. Reply.
    Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S| | PubMed
  70. The Authors' Reply.
    Massie AB, Roberts JP| | PubMed
  71. Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.
    Campos-Varela I, Agudelo EZ, Sarkar M, Roberts JP, Terrault NA| | PubMed
  72. A2 liver transplantation across the ABO barrier: Increasing options in the donor pool?
    Ge J, Roberts JP, Lai JC| | PubMed
  73. Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database.
    Mehta N, Dodge JL, Roberts JP, Yao FY| | PubMed
  74. Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study.
    Mehta N, Guy J, Frenette CT, Dodge JL, Osorio RW, Minteer WB, Roberts JP, Yao FY| | PubMed
  75. A Formula to Calculate Standard Liver Volume Using Thoracoabdominal Circumference.
    Shaw BI, Burdine LJ, Braun HJ, Ascher NL, Roberts JP| | PubMed
  76. Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form.
    Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY| | PubMed
  77. Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study.
    Orandi BJ, Luo X, King EA, Garonzik-Wang JM, Bae S, Montgomery RA, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Osama Gaber A, Segev DL| | PubMed
  78. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
    Radhakrishnan K, Chi A, Quan DJ, Roberts JP, Terrault NA| | PubMed
  79. Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot".
    Mehta N, Heimbach J, Lee D, Dodge JL, Harnois D, Burns J, Sanchez W, Roberts JP, Yao FY| | PubMed
  80. Biases in the reporting of hepatocellular carcinoma tumor sizes on the liver transplant waiting list.
    Samoylova ML, Nigrini MJ, Dodge JL, Roberts JP| | PubMed
  81. Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S| | PubMed
  82. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
    Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D| | PubMed
  83. Race/ethnicity is associated with ABO-nonidentical liver transplantation in the United States.
    Ge J, Roberts JP, Lai JC| | PubMed
  84. Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma.
    Salazar J, Saxena V, Kahn JG, Roberts JP, Mehta N, Volk M, Lai JC| | PubMed
  85. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.
    Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY| | PubMed
  86. 3D T2-weighted and Gd-EOB-DTPA-enhanced 3D T1-weighted MR cholangiography for evaluation of biliary anatomy in living liver donors.
    Cai L, Yeh BM, Westphalen AC, Roberts J, Wang ZJ| | PubMed
  87. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study.
    Samoylova ML, Covinsky KE, Haftek M, Kuo S, Roberts JP, Lai JC| | PubMed
  88. Donor Liver Small Droplet Macrovesicular Steatosis Is Associated With Increased Risk for Recipient Allograft Rejection.
    Choi WT, Jen KY, Wang D, Tavakol M, Roberts JP, Gill RM| | PubMed
  89. Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points.
    Hart A, Schladt DP, Zeglin J, Pyke J, Kim WR, Lake JR, Roberts JP, Hirose R, Mulligan DC, Kasiske BL, Snyder JJ, Israni AK| | PubMed
  90. We Need to Take the Next Step.
    Melcher ML, Roberts JP, Leichtman AB, Roth AE, Rees MA| | PubMed
  91. Biliary complications following living donor hepatectomy.
    Braun HJ, Ascher NL, Roll GR, Roberts JP| | PubMed
  92. Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.
    Pomposelli JJ, Goodrich NP, Emond JC, Humar A, Baker TB, Grant DR, Fisher RA, Roberts JP, Olthoff KM, Gillespie BW, Merion RM| | PubMed
  93. Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant.
    Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N| | PubMed
  94. Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates.
    Braun HJ, Perito ER, Dodge JL, Rhee S, Roberts JP| | PubMed
  95. Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation.
    Braun HJ, Dodge JL, Roll GR, Freise CE, Ascher NL, Roberts JP| | PubMed
  96. Adult living donor liver imaging.
    Cai L, Yeh BM, Westphalen AC, Roberts JP, Wang ZJ| | PubMed
  97. Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story?
    Mehta N, Roberts JP, Yao FY| | PubMed
  98. ABO-Nonidentical Liver Transplantation in the United States.
    Lai JC, Roberts JP| | PubMed
  99. Response to clinical assessments of health status as a potential marker to identify patients who are too sick to undergo transplantation.
    Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge J, Roberts JP, Terrault NA, Feng S| | PubMed
  100. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.
    Orandi BJ, Luo X, Massie AB, Garonzik-Wang JM, Lonze BE, Ahmed R, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL| | PubMed
  101. Utilization of Deceased Donor Kidneys to Initiate Living Donor Chains.
    Melcher ML, Roberts JP, Leichtman AB, Roth AE, Rees MA| | PubMed
  102. The Cost of Fairness.
    Roberts JP| | PubMed
  103. Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.
    Mehta N, Sarkar M, Dodge JL, Fidelman N, Roberts JP, Yao FY| | PubMed
  104. Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy?
    Mehta N, Heimbach J, Hirose R, Roberts JP, Yao FY| | PubMed
  105. Impact of a quality improvement project on deceased organ donor management.
    Olmos A, Feiner J, Hirose R, Swain S, Blasi A, Roberts JP, Niemann CU| | PubMed
  106. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ, Lai JC, Dodge JL, Roberts JP| | PubMed
  107. Transplantation: Allocation of liver transplants-a road to consensus.
    Roberts JP| | PubMed
  108. A Cost-Benefit Analysis of Government Compensation of Kidney Donors.
    Held PJ, McCormick F, Ojo A, Roberts JP| | PubMed
  109. The Evolution of Organ Allocation for Liver Transplantation: Tackling Geographic Disparity Through Broader Sharing.
    Axelrod DA, Vagefi PA, Roberts JP| | PubMed
  110. Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function.
    Niemann CU, Feiner J, Swain S, Bunting S, Friedman M, Crutchfield M, Broglio K, Hirose R, Roberts JP, Malinoski D| | PubMed
  111. Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5.
    Macdonald B, Sewell JL, Harper AM, Roberts JP, Yao FY| | PubMed
  112. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria.
    Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP| | PubMed
  113. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation.
    Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge JL, Roberts JP, Terrault NA, Feng S| | PubMed
  114. Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation.
    Vagefi PA, Dodge JL, Yao FY, Roberts JP| | PubMed
  115. Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm.
    Samoylova ML, Dodge JL, Mehta N, Yao FY, Roberts JP| | PubMed
  116. Does center-specific reporting limit innovation.
    Roberts JP| | PubMed
  117. Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization.
    Feng K, Gupta V, Terrazas E, Yeghiazarians Y, Ports T, Gregoratos G, Tavakol M, Roberts JP, Boyle A| | PubMed
  118. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.
    Goel A, Mehta N, Guy J, Fidelman N, Yao F, Roberts J, Terrault N| | PubMed
  119. Response to letter to the editors.
    Yao FY, Hameed B, Mehta N, Roberts JP| | PubMed
  120. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
    Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY| | PubMed
  121. Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.
    Samoylova ML, Dodge JL, Yao FY, Roberts JP| | PubMed
  122. Quantifying the risk of incompatible kidney transplantation: a multicenter study.
    Orandi BJ, Garonzik-Wang JM, Massie AB, Zachary AA, Montgomery JR, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL| | PubMed
  123. Multiple listings as a reflection of geographic disparity in liver transplantation.
    Vagefi PA, Feng S, Dodge JL, Markmann JF, Roberts JP| | PubMed
  124. Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list.
    Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY| | PubMed
  125. Author response: reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis.
    Lai JC, Kahn JG, Roberts JP| | PubMed
  126. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.
    Asrani SK, Wiesner RH, Trotter JF, Klintmalm G, Katz E, Maller E, Roberts J, Kneteman N, Teperman L, Fung JJ, Millis JM| | PubMed
  127. Left versus right lobe liver donation.
    Roll GR, Roberts JP| | PubMed
  128. Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.
    Mehta N, Dodge JL, Goel A, Roberts JP, Hirose R, Yao FY| | PubMed
  129. Pediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing data for 2002-2012.
    Perito ER, Rhee S, Roberts JP, Rosenthal P| | PubMed
  130. Consumerist responses to scarcity of organs for transplant.
    Neidich E, Neidich AB, Axelrod DA, Roberts JP| | PubMed
  131. Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database.
    Samoylova ML, Dodge JL, Vittinghoff E, Yao FY, Roberts JP| | PubMed
  132. Fatal transplant-associated west nile virus encephalitis and public health investigation-california, 2010.
    Rabe IB, Schwartz BS, Farnon EC, Josephson SA, Webber AB, Roberts JP, de Mattos AM, Gallay BJ, van Slyck S, Messenger SL, Yen CJ, Bloch EM, Drew CP, Fischer M, Glaser CA, WNV Transplant Investigation Team| | PubMed
  133. Decadal analysis of deceased organ donation in Spain and the United States linking an increased donation rate and the utilization of older donors.
    Halldorson J, Roberts JP| | PubMed
  134. Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis.
    Lai JC, Kahn JG, Tavakol M, Peters MG, Roberts JP| | PubMed
  135. Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial.
    Teperman L, Moonka D, Sebastian A, Sher L, Marotta P, Marsh C, Koneru B, Goss J, Preston D, Roberts JP, Spare-the-Nephron Trial Liver Transplantation Study Group| | PubMed
  136. Determinants of second-order bile duct visualization at CT cholangiography in potential living liver donors.
    Keedy AW, Breiman RS, Webb EM, Roberts JP, Coakley FV, Yeh BM| | PubMed
  137. Ex vivo split-liver transplantation: the true right/left split.
    Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE| | PubMed
  138. Left hepatectomy versus right hepatectomy for living donor liver transplantation: shifting the risk from the donor to the recipient.
    Roll GR, Parekh JR, Parker WF, Siegler M, Pomfret EA, Ascher NL, Roberts JP| | PubMed
  139. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.
    Hickey MD, Quan DJ, Chin-Hong PV, Roberts JP| | PubMed
  140. Offer patterns of nationally placed livers by donation service area.
    Lai JC, Feng S, Vittinghoff E, Roberts JP| | PubMed
  141. Center competition and outcomes following liver transplantation.
    Halldorson JB, Paarsch HJ, Dodge JL, Segre AM, Lai J, Roberts JP| | PubMed
  142. Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma.
    Biggins SW, Bambha KM, Terrault NA, Inadomi J, Shiboski S, Dodge JL, Gralla J, Rosen HR, Roberts JP| | PubMed
  143. Impact of outcomes monitoring on innovation and risk in liver transplantation.
    Roberts JP| | PubMed
  144. Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review.
    Rothbaum Perito E, Lau A, Rhee S, Roberts JP, Rosenthal P| | PubMed
  145. Impact of the donor body mass index on the survival of pediatric liver transplant recipients and post-transplant obesity.
    Perito ER, Rhee S, Glidden D, Roberts JP, Rosenthal P| | PubMed
  146. An examination of liver offers to candidates on the liver transplant wait-list.
    Lai JC, Feng S, Roberts JP| | PubMed
  147. Chain transplantation: initial experience of a large multicenter program.
    Melcher ML, Leeser DB, Gritsch HA, Milner J, Kapur S, Busque S, Roberts JP, Katznelson S, Bry W, Yang H, Lu A, Mulgaonkar S, Danovitch GM, Hil G, Veale JL| | PubMed
  148. Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma.
    Park SJ, Freise CE, Hirose R, Kerlan RK, Yao FY, Roberts JP, Vagefi PA| | PubMed
  149. Report of a consensus conference on transplant program quality and surveillance.
    Kasiske BL, McBride MA, Cornell DL, Gaston RS, Henry ML, Irwin FD, Israni AK, Metzler NW, Murphy KW, Reed AI, Roberts JP, Salkowski N, Snyder JJ, Sweet SC| | PubMed
  150. Patient, center and geographic characteristics of nationally placed livers.
    Lai JC, Roberts JP, Vittinghoff E, Terrault NA, Feng S| | PubMed
  151. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
    Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP| | PubMed
  152. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.
    Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, Alonso EM, Philogene MC, Ikle D, Poole KM, Bridges ND, Turka LA, Tchao NK| | PubMed
  153. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
    Klintmalm GB, Davis GL, Teperman L, Netto GJ, Washburn K, Rudich SM, Pomfret EA, Vargas HE, Brown R, Eckhoff D, Pruett TL, Roberts J, Mulligan DC, Charlton MR, Heffron TG, Ham JM, Douglas DD, Sher L, Baliga PK, Kinkhabwala M, Koneru B, Abecassis M, Millis M, Jennings LW, Fasola CG| | PubMed
  154. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.
    Brandman D, Pingitore A, Lai JC, Roberts JP, Ferrell L, Bass NM, Terrault NA| | PubMed
  155. Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease.
    Flohr TR, Bonatti H, Hranjec T, Keith DS, Lobo PI, Kumer SC, Schmitt TM, Sawyer RG, Pruett TL, Roberts JP, Brayman KL| | PubMed
  156. Overweight and obesity in pediatric liver transplant recipients: prevalence and predictors before and after transplant, United Network for Organ Sharing Data, 1987-2010.
    Perito ER, Glidden D, Roberts JP, Rosenthal P| | PubMed
  157. Multidisciplinary management of hepatocellular carcinoma.
    Guy J, Kelley RK, Roberts J, Kerlan R, Yao F, Terrault N| | PubMed
  158. Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations.
    Living Kidney Donor Follow-Up Conference Writing Group, Leichtman A, Abecassis M, Barr M, Charlton M, Cohen D, Confer D, Cooper M, Danovitch G, Davis C, Delmonico F, Dew MA, Garvey C, Gaston R, Gill J, Gillespie B, Ibrahim H, Jacobs C, Kahn J, Kasiske B, Kim J, Lentine K, Manyalich M, Medina-Pestana J, Merion R, Moxey-Mims M, Odim J, Opelz G, Orlowski J, Rizvi A, Roberts J, Segev DL, Sledge T, Steiner R, Taler S, Textor S, Thiel G, Waterman A, Williams E, Wolfe R, Wynn J, Matas AJ| | PubMed
  159. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality.
    Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA| | PubMed
  160. Liver allocation and distribution: possible next steps.
    Washburn K, Pomfret E, Roberts J| | PubMed
  161. Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010.
    Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE| | PubMed
  162. Managing finances of shipping living donor kidneys for donor exchanges.
    Mast DA, Vaughan W, Busque S, Veale JL, Roberts JP, Straube BM, Flores N, Canari C, Levy E, Tietjen A, Hil G, Melcher ML| | PubMed
  163. Do preoperative inflammatory markers impact on outcome after liver transplantation for hepatocellular carcinoma?
    Sapisochin G, Yao FY, Roberts JP| | PubMed
  164. Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy.
    Coffin CS, Mulrooney-Cousins PM, van Marle G, Roberts JP, Michalak TI, Terrault NA| | PubMed
  165. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma.
    Sapisochin G, Fidelman N, Roberts JP, Yao FY| | PubMed
  166. Rex shunt preoperative imaging: diagnostic capability of imaging modalities.
    Kwan SW, Fidelman N, Durack JC, Roberts JP, Kerlan RK| | PubMed
  167. Experience with laparoscopic donor nephrectomy among more than 1000 cases: low complication rates, despite more challenging cases.
    Ahearn AJ, Posselt AM, Kang SM, Roberts JP, Freise CE| | PubMed
  168. Transplanting kidneys without points for HLA-B matching: consequences of the policy change.
    Ashby VB, Port FK, Wolfe RA, Wynn JJ, Williams WW, Roberts JP, Leichtman AB| | PubMed
  169. Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.
    Coffin CS, Mulrooney-Cousins PM, Peters MG, van Marle G, Roberts JP, Michalak TI, Terrault NA| | PubMed
  170. Image of the month. Portal hypertensive biliopathy.
    Martinez AF, Bonacini M, Roberts JP| | PubMed
  171. Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation.
    Ladabaum U, Cheng SL, Yao FY, Roberts JP| | PubMed
  172. Endovascular closure of a portocaval shunt after left lobe liver transplantation using an Amplatzer muscular ventricular septal occluder device.
    Durack J, Bass N, Teitel D, Kerlan R, Roberts J| | PubMed
  173. Transplant surgery fellow perceptions about training and the ensuing job market-are the right number of surgeons being trained?
    Reich DJ, Magee JC, Gifford K, Merion RM, Roberts JP, Klintmalm GB, Stock PG, ASTS Fellowship Training Committee| | PubMed
  174. Gender differences in liver donor quality are predictive of graft loss.
    Lai JC, Feng S, Roberts JP, Terrault NA| | PubMed
  175. Transporting live donor kidneys for kidney paired donation: initial national results.
    Segev DL, Veale JL, Berger JC, Hiller JM, Hanto RL, Leeser DB, Geffner SR, Shenoy S, Bry WI, Katznelson S, Melcher ML, Rees MA, Samara EN, Israni AK, Cooper M, Montgomery RJ, Malinzak L, Whiting J, Baran D, Tchervenkov JI, Roberts JP, Rogers J, Axelrod DA, Simpkins CE, Montgomery RA| | PubMed
  176. Implementation of vascularized composite allografts in the United States: recommendations from the ASTS VCA Ad Hoc Committee and the Executive Committee.
    Cendales L, Granger D, Henry M, Jones J, Langnas A, Levi D, Magee J, Merion R, Olthoff K, Pruett T, Roberts J, Abecassis M, ASTS VCA Ad Hoc Committee and Executive Committee| | PubMed
  177. Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation.
    Yong CM, Sharma M, Ochoa V, Abnousi F, Roberts J, Bass NM, Niemann CU, Shiboski S, Prasad M, Tavakol M, Ports TA, Gregoratos G, Yeghiazarians Y, Boyle AJ| | PubMed
  178. Outcomes of surgical repair of bile leaks and strictures after adult-to-adult living donor liver transplant.
    Melcher ML, Freise CE, Ascher NL, Roberts JP| | PubMed
  179. Comparison of biliary complications in adult living-donor liver transplants performed at two busy transplant centers.
    Melcher ML, Pomposelli JJ, Verbesey JE, McTaggart RA, Freise CE, Ascher NL, Roberts JP, Pomfret EA| | PubMed
  180. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors.
    Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, Josephson SA| | PubMed
  181. Hepatocellular carcinoma: Ablate and wait versus rapid transplantation.
    Roberts JP, Venook A, Kerlan R, Yao F| | PubMed
  182. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome.
    Botha JF, Langnas AN, Campos BD, Grant WJ, Freise CE, Ascher NL, Mercer DF, Roberts JP| | PubMed
  183. Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin.
    Niemann CU, Walia A, Waldman J, Davio M, Roberts JP, Hirose R, Feiner J| | PubMed
  184. Factors influencing liver transplant length of stay at two large-volume transplant centers.
    Washburn WK, Meo NA, Halff GA, Roberts JP, Feng S| | PubMed
  185. The Declaration of Istanbul: review and commentary by the American Society of Transplant Surgeons Ethics Committee and Executive Committee.
    Reed AI, Merion RM, Roberts JP, Klintmalm GB, Abecassis MM, Olthoff KM, Langnas AN| | PubMed
  186. Long-term renal function and cardiovascular disease risk in obese kidney donors.
    Tavakol MM, Vincenti FG, Assadi H, Frederick MJ, Tomlanovich SJ, Roberts JP, Posselt AM| | PubMed
  187. Predictors associated with terminal renal function in deceased organ donors in the intensive care unit.
    Blasi-Ibanez A, Hirose R, Feiner J, Freise C, Stock PG, Roberts JP, Niemann CU| | PubMed
  188. Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation.
    Sharma M, Yong C, Majure D, Zellner C, Roberts JP, Bass NM, Ports TA, Yeghiazarians Y, Gregoratos G, Boyle AJ| | PubMed
  189. Transplant tourism to China: the impact on domestic patient-care decisions.
    Biggins SW, Bambha K, Terrault N, Inadomi J, Roberts JP, Bass N| | PubMed
  190. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
    Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault NA| | PubMed
  191. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.
    Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP| | PubMed
  192. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Balan V, Ruppert K, Demetris AJ, Ledneva T, Duquesnoy RJ, Detre KM, Wei YL, Rakela J, Schafer DF, Roberts JP, Everhart JE, Wiesner RH| | PubMed
  193. CT cholangiography in potential liver donors: effect of premedication with intravenous morphine on biliary caliber and visualization.
    Breiman RS, Coakley FV, Webb EM, Ellingson JJ, Roberts JP, Kohr J, Lutz J, Knoess N, Yeh BM| | PubMed
  194. Accuracy of plain abdominal radiographs in the detection of retained surgical needles in the peritoneal cavity.
    Ponrartana S, Coakley FV, Yeh BM, Breiman RS, Qayyum A, Joe BN, Poder L, Lu Y, Gibbs VC, Roberts JP| | PubMed
  195. Increased severity of renal ischemia-reperfusion injury with venous clamping compared to arterial clamping in a rat model.
    Park Y, Hirose R, Dang K, Xu F, Behrends M, Tan V, Roberts JP, Niemann CU| | PubMed
  196. Central venous pressure monitoring during living right donor hepatectomy.
    Niemann CU, Feiner J, Behrends M, Eilers H, Ascher NL, Roberts JP| | PubMed
  197. Predicting biliary complications in right lobe liver transplant recipients according to distance between donor's bile duct and corresponding hepatic artery.
    Yeh BM, Coakley FV, Westphalen AC, Joe BN, Freise CE, Qayyum A, McTaggart RA, Roberts JP| | PubMed
  198. SIR 2006 Annual Meeting Film Panel Case: Budd-Chiari syndrome in a patient with Cogan syndrome.
    O'Brien MJ, Bloom A, LaBerge JM, Roberts JP, Rosenthal P, Kerlan RK, SIR Foundation| | PubMed
  199. The use of a micro-bubble contrast agent to allow visualization of the biliary tree.
    Roberts JP, Neill A, Goldstein R| | PubMed
  200. Ischemia-reperfusion injury is more severe in older versus young rat livers.
    Park Y, Hirose R, Coatney JL, Ferrell L, Behrends M, Roberts JP, Serkova NJ, Niemann CU| | PubMed
  201. De novo malignancies following liver transplantation: a case-control study with long-term follow-up.
    Yao FY, Gautam M, Palese C, Rebres R, Terrault N, Roberts JP, Peters MG| | PubMed
  202. Mild hypothermia protects obese rats from fulminant hepatic necrosis induced by ischemia-reperfusion.
    Niemann CU, Choi S, Behrends M, Hirose R, Noh J, Coatney JL, Roberts JP, Serkova NJ, Maher JJ| | PubMed
  203. Trends over a decade of pediatric liver transplantation in the United States.
    Feng S, Si M, Taranto SE, McBride MA, Mudge C, Stritzel S, Roberts JP, Rosenthal P| | PubMed
  204. Warm ischemia-induced alterations in oxidative and inflammatory proteins in hepatic Kupffer cells in rats.
    Hirsch J, Hansen KC, Choi S, Noh J, Hirose R, Roberts JP, Matthay MA, Burlingame AL, Maher JJ, Niemann CU| | PubMed
  205. Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years.
    Khalili M, Vardanian AJ, Hamerski CM, Wang R, Bacchetti P, Roberts JP, Terrault NA| | PubMed
  206. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP| | PubMed
  207. Ischemic preconditioning improves energy state and transplantation survival in obese Zucker rat livers.
    Niemann CU, Hirose R, Liu T, Behrends M, Brown JL, Kominsky DF, Roberts JP, Serkova N| | PubMed
  208. Expanded criteria donor kidney allocation: marked decrease in cold ischemia and delayed graft function at a single center.
    Carter JT, Chan S, Roberts JP, Feng S| | PubMed
  209. Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation.
    Roberts JP| | PubMed
  210. Metabolic profiling of livers and blood from obese Zucker rats.
    Serkova NJ, Jackman M, Brown JL, Liu T, Hirose R, Roberts JP, Maher JJ, Niemann CU| | PubMed
  211. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome.
    Cruz E, Ascher NL, Roberts JP, Bass NM, Yao FY| | PubMed
  212. Laparoscopic procurement of kidneys with multiple renal arteries is associated with increased ureteral complications in the recipient.
    Carter JT, Freise CE, McTaggart RA, Mahanty HD, Kang SM, Chan SH, Feng S, Roberts JP, Posselt AM| | PubMed
  213. The use of stents for duct-to-duct anastomoses of biliary reconstruction in orthotopic liver transplantation.
    Kusano T, Randall HB, Roberts JP, Ascher NL| | PubMed
  214. Living donor candidates for right hepatic lobe transplantation: evaluation at CT cholangiography--initial experience.
    Wang ZJ, Yeh BM, Roberts JP, Breiman RS, Qayyum A, Coakley FV| | PubMed
  215. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma.
    Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R, Kerlan R, Venook A, Ascher NL, Emond JC, Roberts JP| | PubMed
  216. Mild hypothermia provides significant protection against ischemia/reperfusion injury in livers of obese and lean rats.
    Choi S, Noh J, Hirose R, Ferell L, Bedolli M, Roberts JP, Niemann CU| | PubMed
  217. Percutaneous salvage of a failing rex shunt.
    Thornton RH, Kerlan RK, Gordon RL, Laberge JM, Wilson MW, Wolanske KA, Roberts JP| | PubMed
  218. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation.
    Shergill AK, Khalili M, Straley S, Bollinger K, Roberts JP, Ascher NA, Terrault NA| | PubMed
  219. Concordance of second-order portal venous and biliary tract anatomies on MDCT angiography and MDCT cholangiography.
    Chen JS, Yeh BM, Wang ZJ, Roberts JP, Breiman RS, Qayyum A, Coakley FV| | PubMed
  220. Serum sodium predicts mortality in patients listed for liver transplantation.
    Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA| | PubMed
  221. Laparoscopic right donor nephrectomy: a large single-center experience.
    Posselt AM, Mahanty H, Kang SM, Stoller ML, Meng MV, Roberts JP, Freise CE| | PubMed
  222. Ethical issues in split versus whole liver transplantation.
    Vulchev A, Roberts JP, Stock PG| | PubMed
  223. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA.
    Olthoff KM, Brown RS, Delmonico FL, Freeman RB, McDiarmid SV, Merion RM, Millis JM, Roberts JP, Shaked A, Wiesner RH, Lucey MR| | PubMed
  224. The influence of portoenterostomy on transplantation for biliary atresia.
    Visser BC, Suh I, Hirose S, Rosenthal P, Lee H, Roberts JP, Hirose R| | PubMed
  225. Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens.
    McTaggart RA, Tomlanovich S, Bostrom A, Roberts JP, Feng S| | PubMed
  226. Use of CT cholangiography to evaluate the biliary tract after liver transplantation: initial experience.
    Miller GA, Yeh BM, Breiman RS, Roberts JP, Qayyum A, Coakley FV| | PubMed
  227. Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time?
    Yao FY, Roberts JP| | PubMed
  228. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy.
    Yao FY, Bass NM, Ascher NL, Roberts JP| | PubMed
  229. Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience.
    Yeh BM, Breiman RS, Taouli B, Qayyum A, Roberts JP, Coakley FV| | PubMed
  230. Influence of graft type on outcomes after pediatric liver transplantation.
    Roberts JP, Hulbert-Shearon TE, Merion RM, Wolfe RA, Port FK| | PubMed
  231. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection.
    Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA| | PubMed
  232. Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups.
    Roberts JP, Wolfe RA, Bragg-Gresham JL, Rush SH, Wynn JJ, Distant DA, Ashby VB, Held PJ, Port FK| | PubMed
  233. Improving liver allocation: MELD and PELD.
    Freeman RB, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM| | PubMed
  234. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores.
    Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP| | PubMed
  235. Cost of organ procurement and transplantation network data collection for a large transplant center.
    Roberts JP, Nikolai B, Tomlanovich S| | PubMed
  236. Expanding the donor pool: can the Spanish model work in the United States?
    Chang GJ, Mahanty HD, Ascher NL, Roberts JP| | PubMed
  237. Role of adult living liver donation in patients with hepatocellular cancer.
    Roberts JP| | PubMed
  238. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL| | PubMed
  239. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
    Posselt AM, Vincenti F, Bedolli M, Lantz M, Roberts JP, Hirose R| | PubMed
  240. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy.
    Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP| | PubMed
  241. Frequent salvage of ruptured renal allografts: a large single center experience.
    Finley DS, Roberts JP| | PubMed
  242. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation.
    McTaggart RA, Gottlieb D, Brooks J, Bacchetti P, Roberts JP, Tomlanovich S, Feng S| | PubMed
  243. Liver and intestine transplantation.
    Roberts JP, Brown RS, Edwards EB, Farmer DG, Freeman RB, Wiesner RH, Merion RM| | PubMed
  244. Pharmacokinetics of cyclosporine pre- and post-liver transplantation.
    Hebert MF, Wacher VJ, Roberts JP, Benet LZ| | PubMed
  245. Intraoperative hemodynamics and liver function in adult-to-adult living liver donors.
    Niemann CU, Roberts JP, Ascher NL, Yost CS| | PubMed
  246. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.
    Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP| | PubMed
  247. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria.
    Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP| | PubMed
  248. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor.
    Rosengard BR, Feng S, Alfrey EJ, Zaroff JG, Emond JC, Henry ML, Garrity ER, Roberts JP, Wynn JJ, Metzger RA, Freeman RB, Port FK, Merion RM, Love RB, Busuttil RW, Delmonico FL| | PubMed
  249. Allograft rejection in pediatric liver transplantation: Comparison between cadaveric and living related donors.
    Toyoki Y, Renz JF, Mudge C, Ascher NL, Roberts JP, Rosenthal P| | PubMed
  250. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts.
    Chang GJ, Liu T, Feng S, Bedolli M, O'rourke RW, Schmidt G, Roberts JP, Stock PG| | PubMed
  251. Donor health assessment after living-donor liver transplantation.
    Diaz GC, Renz JF, Mudge C, Roberts JP, Ascher NL, Emond JC, Rosenthal P| | PubMed
  252. Prioritization of patients with liver cancer within the MELD system.
    Roberts JP| | PubMed